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httpcense.Abstract Objective: The aim of work is to evaluate the role of magnetic resonance imaging in the
assessment of different entities of inﬂammatory breast disorders.
Materials and methods: Eighty-one non-lactating patients with mastitis had been evaluated by post
contrast MR imaging; their ages ranged from 22 to 70 years (Average age: 41.6 years). MRI data
analysis was performed regarding qualitative criteria and parametric color maps for image post pro-
cessing. Diagnosis was made up regarding resolution in follow up sessions for simple mastitis and
biopsy were done for cases with suspicious imaging ﬁndings.
Results: Mammary interstitial edema with no masses or abnormal enhancement was elicited in
28.4% (n= 23/81). T2-weighed and post contrast series were the sequences of choice to rely upon
in evaluation. T2 had demonstrated lesions in 64.2% (n= 52/81) and contrast uptake was detected
in 68% (n= 55/81). Quantitative analysis was overlapping.
MR imaging had displayed sensitivity, speciﬁcity and accuracy of 87.5%, 72.3%, and 75.4% respec-
tively in differentiating benign forms of mastitis from malignant ones.
Conclusion: In inﬂammatory breast disorders, MR imaging can precisely delineate disease extent
and monitor response to therapy. Immediate distinction between infectious/non-infectious and
malignant mastitis is difﬁcult to be obtained.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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In general mastitis is inﬂammation of the breast that may or
may not be accompanied by infection. The term mastitis is of-
ten used synonymous with breast infection (1), but strictly
speaking mastitis is inﬂammation of the breast irrespective of
the cause (2).
Having mastitis does not raise the woman’s risk of develop-
ing breast cancer. However, an uncommon type of breast can-
cer known as the inﬂammatory breast cancer (IBC) hasProduction and hosting by Elsevier B.V.
.04.004
488 S.M. Mansour, A. Abolfotoohsymptoms that are similar to mastitis and can be sometimes
mistaken as infection (3).
Imaging plays several key roles in the diagnosis and assess-
ment of IBC. These include characterization of the known
tumor, delineation of locoregional disease in the ipsilateral
and contralateral breast and regional lymph node basins,
diagnosis of distant metastases, and evaluation of treatment
response (4).
Complete resolution is usually the rule in most cases of
mastitis. If after 10 days of antibiotics symptoms of mastitis
do not dissipate, inﬂammatory carcinoma should be ruled
out and punch skin biopsy skin biopsy (that included skin
and dermal lymphatics) should be performed (2).
If after biopsy the diagnosis remains unclear, breast MR
may help to (a) demonstrate the success of the antibiotic treat-
ment and (b) diagnose coexisting or confounding inﬂamma-
tory carcinoma (5).
The purpose of the study was to assess the impact of MR
imaging in the evaluation of different entities of inﬂammatory
breast disorders and discuss its potential ability to differentiate
infectious/non-infectious from malignant mastitis.2. Materials and methods
2.1. Materials
Eighty-one non-lactating female patients were clinically or
pathologically diagnosed of mastitis had been referred to the
Radiology Department, Women’s imaging unit, Cairo Univer-
sity from June 2010 to July 2011. All patients gave informed
consent. Their ages ranged from 22 to 70 years (Average age:
41.6 years).
Lactating females or cases with dermal rather mammary
inﬂammation had been excluded from the evaluation.
Cases were classiﬁed into three main groups of mastitis
according to previous retrospective study performed on 2009
[2], which had postulated a three group classiﬁcation for the
different entities of inﬂammatory breast disorders as follows:
group 1 infectious mastitis; group 2 non-infectious mastitis,
and group 3 malignant mastitis.
The categories in our work were in group 1 simple, compli-
cated (abscess and infected cysts) and speciﬁc mastitis (T.B.);
group 2 periductal mastitis, granulomatous mastitis, diabetic
mastopathy and secondary mastitis (fat necrosis, postoperative
and chemo-radiotherapy changes, scleroderma, systemic lupus
erythematosus, sarcoidosis) and group 3 inﬂammatory breast
carcinoma (IBC).
No malignant abscess cases were detected through the re-
search duration.
Cases with post operative chemo-radiotherapy changes
(n= 14) are known cases of breast cancer with management-
related likely inﬂammatory changes.
2.2. Methods
All patients were subjected to complete medical history and
full clinical examination by their referring physicians. Cases
were obliged to bring such data at the time of imaging.
Ultrasound examination was performed for all the cases by
8–12 MHz linear array transducer (General Electric (GE), Lo-
gic 7 machine).Full Field Digital Mammography was performed using GE
Senograph 2000 Machine. Standard craniocaudal and medio-
lateral oblique views were obtained; with the axilla included
in the latter. Regarding the clinical condition of the breast (de-
gree of inﬂammation), mammography was not feasible in all
cases; it was performed in 53 out of 81 cases (64.5%).
2.2.1. Magnetic resonance imaging
Sequentional post contrast MRI was performed for all cases
using a 1.5-T magnet (Gyroscan Entra, Philips medical sys-
tems, Netherland).
MR examination of the breast was requested for more pre-
cise evaluation of the abnormality extent and/or speciﬁcation
of the etiological entity (if possible).
Cases were examined ﬁrst by pre-contrast sequences: Axial
T1-weighted sequence spinecho (SE)-(TR/TE 500/5.3 ms),
sagittal and axial T2-weighted sequences SE (TR/TE 120/
4.9 ms) and axial T2-weighted inversion recovery (IR)-(TR/
TE 80/6.5 ms). For all the aforementioned sequences slice
thickness = 4 mm, matrix = 512 · 192, ﬂip angle = 90 and
FVO= 34–37 cm. Six dynamic 3D ‘‘T1 High Resolution Iso-
tropic Volumetric Examination’’ THRIVE acquisition was
used – 1 before and 5 after power injection of 0.1 mmol/kg
BW of contrast (Gd-DTPA) with the parameters (TR/TE
2.8/9 ms) and slice thickness = 1.5 mm.
2.3. Image analysis
Image analysis and imaging–guided biopsy had been per-
formed by qualiﬁed consultant of Radiology (M.S.), who is
M.D. certiﬁed (lecturer) and has 9 years experience in breast
MR imaging and interventional procedures performance.
Second look MR image analysis and surgical procedures
had been performed by qualiﬁed consultant of surgery
(A.A.), M.D. certiﬁed (lecturer) 9 years experience in breast
surgery and imaging.
The authors were blinded about the mammography and
ultrasound ﬁndings as well as the pathology results at the time
of initial evaluation. Also they were blinded about each other
MRI analysis. At the stage of ﬁnal evaluation, there was mul-
tidisciplinary discussion of cases between the consultants.
On breast MRI, data analysis was performed regarding
qualitative (morphology) and quantitative (kinetic) criteria.
In the pre-contrast series, ﬁndings indicative of inﬂamma-
tion had been looked for: (1) diffuse or focal skin thickening,
(2) diffuse or sectoral interstitial edema, (3) focal collections,
(4) diffuse soft tissue inﬁltrations, (5) focal mass and (6) lymph
node enlargement.
Post contrast series were assessed for enhancement
recognition.
The different patterns of enhancement of the inﬂammatory
entities included in the study will be discussed in the results sec-
tor as it has been retrospectively assessed.
Kinetic analysis was applicable using a Phillips Advantage
windows workstation with functional Tool software. For im-
age post processing; region of interest (ROI) measurement of
abnormally enhancing areas was performed using parametric
color maps to determine the lesion enhancement rate peak
and time.
Lesions that are strongly and rapidly enhancing were dis-
played in red, whereas slowly or weakly enhancing lesions
had appeared blue or green. Automated Slope enhancement
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centage (MRE%) were obtained.
Ultrasound guided core biopsies of the breast were per-
formed in 66.7% (n= 54/81) of the cases using 14-gauge
needle.
In cases of IBC, punch skin biopsy was done. Biopsy site
from the breast parenchyma was also performed guided by
the degree of tissue induration (the harder the tissue; the more
liable to be pathologically involved).
Surgical biopsy had been performed for six cases as follows:
– Three cases of IBC had shown inconclusive tissue sample by
previous US guided core biopsy (granulation tissue with no
malignant cells detected).
– One case of granulomatous mastitis and another one with
tuberculous (T.B.) mastitis had undergone partial mastec-
tomy with latissimus dorsi ﬂap application as the disease
was extensive and resistant to medical treatment.
– One case of post operative fat necrosis; in such case the
lesion was indistinct by ultrasound it was only noted in rela-
tion to the scar region at MR imaging.Table 1 The incidence of pathological entities included in the
study.
Pathology of mastitis No. of lesion/patient (%)
Group 1: Infectious 31 38.2
*Simple 9
*Complicated 13
Abscess cavity 6
Infected cysts 7
*Speciﬁc mastitis 9
Tuberculosis (T.B.) 9
Group 2: Non-infectious 34 42
*Periductal mastitis/duct ectasia 2
*Granulomatous mastitis 3
*Diabetic mastopathy 2
*Secondary mastitis 27
Fat necrosis 6
Postoperative/chemo-radiotherapy 14
Scleroderma 2
Systemic lupus erythematosus 3
Sarcoidosis 2
Group 3: Malignant 16 19.8
*Inﬂammatory carcinoma 16
Total 81 100Nodal ultrasound guided core biopsy was performed in 26
cases as follows: 68.7% of IBC (n= 11/16), 77.7% of tubercu-
lous (n= 7/9), and all of simple mastitis, scleroderma, sarcoid-
osis and systemic lupus cases.
Surgical nodal biopsy was done for two cases of IBC.
The choice of using surgical vs US guided core biopsy of ax-
illary nodes was decided according to the size and location of
the node of question.
Fine needle aspiration cytology of axillary nodes was per-
formed in three IBC and two T.B. cases.
Abscess cavities (n= 6), infected cysts (n= 7) and postop-
erative collections (n= 4/14 cases) were drained under US
guidance. Cytological assessment was then performed.
All cases of simple mastitis (n= 9) and active periductal
mastitis (n= 2) were followed up after 1 month and 3 months
by ultrasound and post contrast MRI respectively to ensure
condition amelioration. Follow up request and duration was
decided by the referring physician.
For statistical analysis, software (SPSS for Windows, ver-
sion 10.0.1, 1999; SPSS, Chicago, Ill) had been used.
3. Results
The current study included 81 non-lactating patients that were
complaining of mastitis. The frequency and relative frequen-
cies (percentage) of cases included under each pathological en-
tity listed in Table 1.
Groups 1 and 2 represented infectious and non-infectious
forms of mastitis in the study (65/81 cases-80.3%) and group
3 represented malignant mastitis in the form of IBC (16/81
cases-19.7%).
Group 1: 31 cases (age range: 22–56 years, mean: 35.6 and
Std: 7.3), group 2: 34 cases (age range: 24–65 years, mean: 41.3
and Std: 9.3) and group 3: included the malignant entity of 16
cases (age range: 40–70 years, mean: 53.8 and Std: 8.4).
Mammary interstitial edema with no masses or abnormal
contrast uptake was elicited in 28.4% (n= 23/81) (Fig. 1) –
Table 2.
T2WI FSE and post contrast series were the sequences of
choice to rely upon in evaluation.
T2 had demonstrated lesions in 64.2% (n= 52/81) seen in
17 cases of group 1, 21 cases in group 2 and 14 cases in group3; that had elicited the following patterns: (1) bright, (2) inter-
mediate-bright and (3) intermediate-low patterns – Table 3.
In groups 1 and 2 (benign mastitis, n= 38/52); T2 WI had
shown bright signal in 36.9% (n= 14/38), intermediate-
bright signal in 44.7% (n= 17/38) (Figs. 2 and 3) and inter-
mediate-low signal in 18.4% (n= 7/38). In group 3 (malig-
nant mastitis, n= 14/52); T2 WI detected masses of
intermediate-low soft tissue inﬁltration in 100% (14/14) of
IBC cases (Fig. 5).
Contrast uptake was detected in 68% (n= 55/81); benign
mastitis (groups 1 and 2) had represented 20 cases for each
and 15 cases in group 3 of malignant mastitis. Retrospective
analysis of enhancement patterns were as follows: (1) marginal
(Fig. 2), (2) discrete patchy, (3) focal mass (Fig. 4), (4)
combined focal and patchy, and (5) inﬁltrative diffuse
enhancement (Figs. 3 and 5) – Table 4.
Patterns of contrast enhancement in benign mastitis
(n= 40/55) were marginal in 32.5% (n= 13/40), discrete pat-
chy in 20% (n= 8/40), focal mass in 27.5% (n= 11/40), com-
bined focal and patchy 17.5% (n= 7/40) and inﬁltrative
diffuse enhancement 2.5% (n= 1/40).
Group 3 that represents malignant mastitis in the form of
IBC (n= 15/55) had shown inﬁltrative diffuse enhancement
pattern in 80% of these cases (n= 12/15). Discrete patchy, fo-
cal mass and combined focal and patchy enhancement patterns
had been displayed by the remaining three cases: one case for
each pattern.
Quantitative analysis was applied for the enhancing lesions
regarding MRE% and the curve pattern.
For the sake of the patient, the worst curve was the one to
be considered for lesions with different curve patterns, espe-
cially when malignant mastitis was suspected.
MRE% range of 70–150% were detected in 60% (n= 33/
55), 150–250% in 27.3% ( n= 15/55), >250% in 12.7%
(n= 7/55).
Fig. 1 Known case of metatstatic non-Hodgkin lymphoma. Axial (a) T2-weighted, (b) T2-STIR and (c) 3D MIP reconstructed T2-STIR
show left axillary pathologically enlarged and amalgamated nodes. Ipsilateral upper outer quadrant tissue edema of patchy bright SI. Note
the right side benign looking axillary nodes with preserved fatty hilum. (d) Post contrast axial image at 2.4 min of the dynamic series with
color overlay. (e) Time/SI analysis of one of the enlarged nodes shows early uptake at 120 s. with corresponding SI% of 109% and type III
(early wash out) curve.
490 S.M. Mansour, A. AbolfotoohBenign mastitis cases had shown 70–150% in 67.5%
(n= 27/40), 150–250% in 20% (n= 8/40), and >250% in
12.5% (n= 5/40). In Malignant mastitis, cases had shown
70–150% in 40% (n= 6/15), 150–250% in 46.7% (n= 7/
15), and >250% in 13.3% (n= 2/15).
Type I of continuous rise curve pattern (suggestive of benign
kinetics) was noted in 34.5% (n= 19/55), type II of plateau
curve pattern (borderline) was seen in 54.5% (n= 30/55)
and type III most likely malignant curve pattern with early
wash out was seen in 11% (n= 6/55).
Groups 1 and 2 of benign mastitis had shown type I curve
in 47.5% (n= 19/40) (Figs. 2 and 4), and type II curve in
47.5% (n= 19/40), where delayed peak of contrast uptake
that may suggest probably benign kinetics displayed in 10
cases and early peak with suspicious impression in 9 cases.Type III curve pattern was elicited by only 5% (n= 2/40)
(Fig. 3) of these cases.
Group 3 (malignant mastitis) had presented the following
curve patterns: delayed peak plateau curve pattern in 6.6%
(n= 1/15), early peak plateau curve pattern in 66.7%
(n= 10/15) and type III pattern in 26.7% (n= 4/15) (Fig. 5).
Contrast-enhancement with no deﬁnite mass detection on
T2WI had been demonstrated in three cases 7% (n= 6/81)
as follows: three simple mastitis, two periductal mastitis and
one IBC cases.
Diabetic mastopathy cases and one case of fat necrosis had
shown no appreciable contrast uptake.
Skin thickening was noted in 55.5% (n= 45/81). Out of
them twenty cases had shown associate post contrast skin
enhancement (n= 21/45–46.6%); these cases include: 14 IBC
Table 2 Inﬂammatory Breast Entities with Solo Breast
Edema in our Study.
Edema e´ no masses (n= 23 cases) No.
Group 1: Infectious 31
Simple 6
Abscess –
Infected cysts –
T.B. 5
Group 2: Non-infectious 34
Periductal mastitis –
Granulomatous mastitis –
Diabetic mastopathy –
Fat necrosis –
Postoperative-chemotherapy 4
Scleroderma 2
Systemic lupus 3
Sarcoidosis 2
Group 3: Malignant 16
IBC 1
Total 23/81
MRI of inﬂammatory breast disorders 491cases (Fig. 5), and one case of granulomatous mastitis (Fig. 3)
and six cases of the post operative chemo-radiotherapy sector.
T1WI was only helpful in some cases of complicated cysts,
abscesses and fat necrosis masses. Such lesions had shown
characteristic bright signal intensity. Suppressed lesions in
the post contrast THRIVE series verify fatty elements
(Fig. 4) suggestive of fat necrosis especially if there was history
of trauma or previous interventional procedure.
Concerning axillary nodes, they were detected in 74 cases
as follows: Average sized in 27.1% (n= 22/81) (Fig. 5), en-Table 3 T2-weighted signal intensities of the current inﬂammatory
Mastitis/T2 SI; n= 52/81 cases Bright
Group 1: Infectious (n = 17/31)
Simple –
Abscess 3
Infected cysts 7
T.B. –
Total 10/17 (58.8)
Group 2: Non-infectious (n = 21/34)
Periductal mastitis –
Granulomatous mastitis –
Diabetic mastopathy –
Fat necrosis 4
Postoperative-chemotherapy –
Scleroderma –
Systemic lupus –
Sarcoidosis –
Total 4/21 (19.1)
Group 3: Malignant (n = 14/16)
IBC –
Total –
Note: Data are reported as number (percent).
SI = Signal intensity.larged discrete in 60.5% (n= 49/81) (Figs. 2 and 3) and
enlarged amalgamated in two T.B. cases and in one case of
pathologically proven metastatic non-Hodgkin lymphoma
(n= 3/81–3.57%). Enlarged lymph nodes in the latter case
had compressed the axillary vein; consequent ipsilateral breast
congestion and resultant simple mastitis took place (Fig. 1).
Such case had performed surgical resection of the pathological
axillary nodes. Subsequent fade out of the mastitis noted in the
follow up examination.
Indistinct central fatty hilum was noted in 11 cases of the
pathologically enlarged lymph nodes (Fig. 1), almost all of
them were IBC (10 cases).
Axillary nodes could not be depicted in 8.6% (n= 7/81) as
they were outside the ﬁeld of view. Nodes kinetic were non-
speciﬁc; SI% was within 80–130%. Peak of contrast uptake
was early in 23% (n= 17/74) cases and delayed in 77%
(n= 57/74) cases followed by wash out.
In the current study dynamic post contrast MRI had dis-
played true positive outcome in 14 cases, true negative in 47
cases, false positive in 18 cases and false negative in two cases.
MRI had shown sensitivity, speciﬁcity, accuracy, positive
predicative value and negative predicative value of 87.5%,
72.3%, 75.4%, 44% and 96% respectively regarding its ability
to evaluate inﬂammatory breast disorders.
4. Discussion
Breast infection can occur in healthy, non-lactating women of
all ages. It remains a challenge to distinguish acute mastitis
from malignancy, especially form inﬂammatory breast carci-
noma (IBC), by clinical or imaging features (6).
Unfortunately, there is a paucity of references discussing
the role of MRI in evaluating inﬂammatory breast disorders.breast disorders.
Intermediate-bright Intermediate-low
– –
3 –
– –
2 2
5/17 (29.4) 2/17 (11.8)
– –
3 –
1 1
2 4
6 –
– –
– –
– –
12/21 (57.1) 5/21 (23.8)
– 14
– 14/14 (100)
Fig. 2 Right breast tuberculous abscess. (a) Gray-scale US image shows false impression of soft tissue inﬁltration. Axial (b) T2-weighted
and (c) 3D MIP reconstructed T2 STIR show thick-walled multi-locular cystic lesion of intermediate-high SI attributed to its turbid
inspissated content. The entire extend of the right breast abscess as well as the ipsilateral enlarged axillary node can be easily seen in (c). (d)
Axial THRIVE image 3.3 min post contrast with color overlay, shows intense marginal enhancement of the abscess cavity. (e) Time/SI
analysis shows delayed peak of contrast uptake at 387sec. with corresponding SI% of 238–195% and type I (continuous rise) benign curve
pattern.
492 S.M. Mansour, A. Abolfotooh
Fig. 3 Right breast non-speciﬁc granulomatous mastitis. (a) Gray-scale US image shows false impression of soft tissue inﬁltration. Axial
(b) T2-weighted and (c) T2 STIR images show the breast is studded with multiple variable sized complicated cystic spaces mingled with
diffuse tissue inﬁltration of intermediate-high SI. Note right diffuse skin thickening, peri-pectoral edema and ipsilateral axillary enlarged
node. (d) Axial THRIVE image 3.3 min post contrast with color overlay shows intense enhancement of the breast inﬁltration and marginal
enhancement of the associate cystic spaces. Note faint insigniﬁcant skin enhancement. (e) Time/SI analysis shows early peak of contrast
uptake at 89sec. with corresponding SI% of 126% and type III (early wash out) curve pattern.
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Fig. 4 Left breast post malignant lumpectomy fat necrosis. Axial (a) T1-weighted and (b) T2-STIR that shows oval-shaped mass of fat-
near SI related to the scar line that had been suppressed in (b) conﬁrming fatty components. (c) Axial THRIVE image 8 min post contrast
with color overlay shows heterogenous enhancement. (d) Time/SI analysis shows delayed peak of contrast uptake at 393 s. with
corresponding SI% of 81% and type I benign curve pattern.
494 S.M. Mansour, A. AbolfotoohFischer et al. (7) in 1994 stated that neither signal behavior
nor signal/time relation were suitable to differentiate between
malignant and benign changes. They concluded that inﬂamma-
tory changes of the female breast are not indicated to be exam-
ined with MR imaging.
Rieber et al. (5) in 1997 also reported MRI breast to show
no signiﬁcant difference between mastitis and inﬂammatory
carcinoma, and Al-Khawari et al. (8) stated that the inclusion
of chronic inﬂammatory lesions in their study was the main
reason for a reduced MRI accuracy since such modality is
not a good tool for the differentiation of benign from
malignancy in such a clinical situation.
In the current study dynamic post contrast MRI had
displayed sensitivity, speciﬁcity, accuracy, positive predictive
value and negative predictive value of 87.5%, 72.3%, 75.4%,
44% and 96% respectively in the evaluation of inﬂammatory
breast disorders.
Renz et al. (6) in 2008 compared the ability of MRM exam-
inations in distinguishing inﬂammatory breast carcinomas
from acute mastitis. They had found out that considering mul-
tiple dynamic and morphological MRM criteria seems to have
the potential for a differential diagnosis.
Inﬂammatory breast cancer (IBC) being rare is often mis-
diagnosed as mastitis or generalized dermatitis (9).IBC cases in the current study using MR imaging had been
evaluated probably regarding the actual extend of the neo-
plasm, associate dermal, lymph node and chest wall involve-
ment (Fig. 5). Concerning the previously mentioned data;
response to the neoadjuvant therapy for such cases could be
easily followed up.
In this study, the following features were observed more of-
ten in IBC cases: Intermediate-low SI in T2WI, early contrast
uptake (blooming sign), and in one case there was additional
peri- and intramuscular pectoral edema and enhancement
(Fig. 5). The aforementioned ﬁndings had helped in distin-
guishing IBC from chronic inﬂammatory conditions especially
granulomatous mastitis (Figs. 5 and 3).The latter had shown
differential T2 WI SI of intermediate – high pattern.
T2-weighted signal hyperintensity within the viable
(enhancing) portion of the lesion is highly suggestive of benign
histology (10).
Qualitative criteria especially T2-weigthed SI and presence
of contrast uptake were the items that helped during the eval-
uation in signiﬁcant number of cases.
Through analyzing the different patterns of contrast uptake
elicited in the study, we could observe that: benign mastitis
(groups 1 and 2) had shown rather comparable presentation
of marginal (32.5%), discrete patchy (20%), focal mass
Fig. 5 Right inﬂammatory breast cancer. Axial (a) T2-weighted and (b) T2-STIR images that show asymmetrical enlargement of the
right breast, diffuse soft tissue inﬁltration and distortion of intermediate-low SI, considered edematous changes, skin thickening, nipple
retraction, peri- and intramuscular pectoral edema. (c) Axial THRIVE image 3 min post contrast with color overlay shows intense
enhancement of the breast inﬁltration and avid skin enhancement. Note pectoral enhancement. (d) Time/SI analysis shows early peak of
contrast uptake at 190 s. with corresponding SI% of 83–104% and type III (early wash out) curve pattern.
MRI of inﬂammatory breast disorders 495(27.5%) and combined focal and patchy (17.5%) enhancement
patterns. The least presentable was the inﬁltrative diffuse
enhancement with dramatic low value of 2.5%. On the other
side, malignant mastitis (group 3) mostly had shown inﬁltrative
diffuse enhancement pattern in 80% of these cases (n= 12/15).
Quantitative analysis has been a recognizable limitation in
the MRI assessment of inﬂammatory breast disorders. Data
had displayed overlap: some benign lesions had shown con-
trast uptake peak of >250% and early wash out curve pattern,
on the other side some malignant lesions had shown peak of
80–150% and continuous rise curve. Such condition had
resulted in upgrading of some benign conditions and conse-
quently had subjected some patients to unnecessary interven-
tional procedures.
The previously mentioned ﬁndings may be attributed to
that mastitis is a very vascular breast condition whether benign
or malignant that displays different variable and overlapping
patterns of angiogenesis.
In Inﬂammatory breast disorders; contrast uptake and ki-
netic criteria could be used in follow up of chemotherapy.The aforementioned idea is recommended to be thoroughly
studied as a continuation to the current work.
Performed MRI examination in our work was able to: (1)
Estimate the actual extend of the breast inﬂammatory disease
by making use of the multiplanar capability of the MRI, espe-
cially in large lesions that could not be probably assessed by
ultrasound. (2) Conﬁrm the nature of the lesion of concern
whether being purely cystic, purely solid or complex as some-
times complicated cystic masses may mimic solid lesions on
ultrasound examination.
We had to admit that in spite of sometimes MRI was able
to differentiate between benign mastitis from malignant enti-
ties yet failure to achieve condition improvement had necessi-
tated biopsy no matter what.
Another limitation was the difﬁculty in differentiating
between reactionary and inﬁltrated axillary lymphadenopa-
thy due to (1) inability to make sure about fatty hilum
inﬁltration in some cases, such ﬁnding was much more evi-
dent by real-time ultrasound rather than MRI and (2) ki-
netic criteria was no help as even normal lymph nodes do
Table 4 Patterns of enhancement of the inﬂammatory breast disorders included in the study.
Mastitis/CE; n= 55/81 cases Marginal Discrete patchy Focal mass Combined Diﬀuse
Group 1: Infectious (n = 20/31)
Simple – 3 – – –
Abscess 4 – – 2 –
Infected cysts 7 – – – –
T.B. 1 1 2 – –
Total 12/20 (60) 4/20 (20) 2/20 (10) 2/20 (10) –
Group 2: Non-infectious (n = 20/34)
Periductal mastitis 1 1 – – –
Granulomatous mastitis – – – 2 1
Diabetic mastopathy – – – – –
Fat necrosis – – 5 – –
Postoperative-chemotherapy – 3 4 3 –
Scleroderma – – – – –
Systemic lupus – – – – –
Sarcoidosis – – – – –
Total 1/20 (5) 4/20 (20) 9/20 (45) 5/20 (25) 1/20 (5)
Group 3: Malignant (n = 15/16)
IBC – 1 1 1 12
Total – 1/15 (6.7) 1/15 (6.7) 1/15 (6.6) 12/15 (80)
Note: Data are reported as number (percent).
CE = Contrast enhancement.
496 S.M. Mansour, A. Abolfotoohshow shooting contrast uptake and early wash out curve
pattern.
During our work, there were some benign examples of mas-
titis that is likely to be confused with malignancy among those
are: fat necrosis, diabetic mastopathy, T.B. mastitis and sec-
ondary mastitis due to sarcoidosis, scleroderma and systemic
lupus.
Fat necrosis is an example of chronic inﬂammatory process
resulting from injury to breast fat; it is considered the great
mimicker of breast cancer (11). When multiple signs typical
of fat necrosis are present, Biopsy may be deferred and routine
or short-term follow-up may be selected on the basis of the de-
gree of conﬁdence in the imaging diagnosis (12).
In this work fat necrosis was diagnosed in six cases; the fol-
lowing ﬁndings were concerned in suggestion: (1) superﬁcial or
peripheral location, (2) concordant history of trauma or sur-
gery, (3) signal isointense to fat, and (4) peripheral enhance-
ment. Such variables were based upon a study performed by
Daly et al. (12) in 2008.
The association between diabetic mastopathy and type 1
diabetes mellitus of long duration has been reported (13).
We had evaluated two cases belonging to such entity one of
them had shown focal hard ill-deﬁnd mass and the other one
presented with diffuse unilateral breast inﬂammation. Biopsy
had conﬁrmed the diagnosis for the two cases.
Tuberculosis is classiﬁed as primary when the breast lesion
is the only manifestation and secondary when there is demon-
strable focus elsewhere (14,15). In the study there were nine
breast T.B. cases; all of them had displayed uni-/bilateral path-
ologically enlarged axillary lymphadenopathy. Five cases had
shown diffuse uni-/bilateral interstitial edema, one case had
shown abscess cavity (Fig. 2), one case with organized collec-
tion and two cases with intramammary enlarged nodes. Three
cases had shown additional breast and nodal coarse calciﬁca-tions. Most of these cases were young (n= 7/9 cases; age
range = 22–35 years), small body built and of low socioeco-
nomic level. Again biopsy conﬁrmed the diagnosis as well as
positive tuberculin test.
Skin thickening and edema in an untreated breast on MR
images, as on mammograms, may be signs of malignancy,
especially of inﬂammatory carcinoma. In a treated breast, these
features are frequently observed after radiation therapy (10).
Skin thickening was noted in more than half of the current
study cases (n= 45/81–55.5%). Associate avid skin enhance-
ment that may suggest an element of soft tissue inﬁltration;
noted in 46.6% (n= 21/45); most of them were IBC (n=
14/21–66.6%).
In conclusion, Breast MR cannot be used to distinguish
infectious/non-infectious mastitis from inﬂammatory carci-
noma. It is difﬁcult to obtain immediate distinction and when
mastitis persists after medical treatment, biopsy is necessary.
Dynamic post contrast breast MR can precisely delineate
disease extent and monitor response to therapy whether it is
medical therapy in benign mastitis or chemotherapy in case
of inﬂammatory carcinoma.
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